Items where Author is Milton, Nathaniel G.N.

Milton, Nathaniel G.N. and Harris, J. Robin (2009) Polymorphism of amyloid-ß fibrils and its effects on human erythrocyte catalase binding. Micron, 40 (8). pp. 800-810. ISSN 0968-4328

Milton, Nathaniel G.N. (2008) Homocysteine inhibits hydrogen peroxide breakdown by catalase. Open Enzyme Inhibition Journal, 1 . pp. 34-41. ISSN 1874-9402

Milton, Nathaniel G.N. (2005) Phosphorylated amyloid-ß: the toxic intermediate in Alzheimer's disease neurodegeneration. Subcellular Biochemistry, 38 . pp. 381-402. ISSN 0306-0225

Milton, Nathaniel G.N. (2004) Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment. Drugs & Aging, 21 (2). pp. 81-100. ISSN 1170-229X

Milton, Nathaniel G.N. (2002) Anandamide and noladin ether prevent neurotoxicity of the human amyloid-ß peptide. Neuroscience Letters, 332 (2). pp. 127-130. ISSN 0304-3940

Milton, Nathaniel G.N. (2002) The amyloid-β peptide binds to cyclin B1 and increases human cyclin-dependent kinase-1 activity. Neuroscience Letters, 322 (2). pp. 131-133. ISSN 0304-3940

Byrne, D.J. and Jagroop, I.A. and Montgomery, H.E. and Thomas, M. and Mikhailidis, D.P. and Milton, Nathaniel G.N. and Winder, A.F. (2002) Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk. Journal of Clinical Pathology, 55 (4). pp. 280-285. ISSN 0021-9746

Milton, Nathaniel G.N. (2001) Inhibition of catalase activity with 3-amino-triazole enhances the cytotoxicity of the Alzheimer’s amyloid-ß peptide. NeuroToxicology, 72 (6). pp. 767-774. ISSN 0161-813X

Milton, Nathaniel G.N. (2001) Phosphorylation of amyloid-ß at the serine 26 residue by human cdc2 kinase. NeuroReport, 12 (17). pp. 3839-3844. ISSN 0959-4965

Milton, Nathaniel G.N. and Mayor, Neema P. and Rawlinson, John (2001) Identification of amyloid-ß binding sites using an antisense peptide approach. NeuroReport, 12 (11). pp. 2561-2566. ISSN 0959-4965

Milton, Nathaniel G.N. (2006) Anti-sense peptides. In: Harris, J.R. and Graham, J. and Rickwood, D., (eds.) Cell biology protocols. John Wiley, Chichester, pp. 353-358. ISBN 9780470847589

Milton, Nathaniel G.N. (2006) Interactions between amyloid-ß and enzymes. In: Harris, J.R. and Graham, J. and Rickwood, D., (eds.) Cell biology protocols. John Wiley, Chichester, pp. 359-363. ISBN 9780470847589

Milton, Nathaniel G.N. (2006) Amyloid-ß phosphorylation. In: Harris, J.R. and Graham, J. and Rickwood, D., (eds.) Cell biology protocols. John Wiley, Chichester, pp. 364-368. ISBN 9780470847589

Milton, Nathaniel G.N. (2005) Phosphorylated Amyloid-ß 1-43 protein and its use in the treatment of Alzheimer's disease. European Patent Application Number EP 04025899.8 - R51(4) intention to Grant issued 19/04/2007 (Publication Number EP1538163).

Milton, Nathaniel G.N. (2004) Peptides for use in the treatment of Alzheimer's disease. United States Patent Application Number US 10/415383 (Publication Number US 2004/0072753).

Milton, Nathaniel G.N. (2003) Peptides for use in the treatment of Alzheimer's disease. European Patent Application Number EP 01980678.5 – R51(4) intention to Grant issued 19/02/2007 (Publication Number EP1363939).

Milton, Nathaniel G.N. (2002) Peptides for use in the treatment of Alzheimer's disease. International Patent Application Publication Number WO 02/36614.

Harris, J. Robin and Milton, Nathaniel G.N. (2010) Cholesterol in Alzheimer's disease and other amyloidogenic disorders. Subcellular Biochemistry, 51 . pp. 47-75. ISSN 0306-0225

Milton, Nathaniel G.N. and Harris, J. Robin (2010) Human islet amyloid polypeptide fibril binding to catalase: a transmission electron microscopy and microplate study. ScientificWorldJournal, 10 . pp. 879-893. ISSN 1537-744X

Milton, Nathaniel G.N. and Chilumuri, Amrutha and Rocha-Ferreira, Eridan and Nercessian, Amanda N. and Ashioti, Maria (2012) Kisspeptin prevention of Amyloid-β Peptide neurotoxicity in vitro. ACS chemical neuroscience, 3 (9). pp. 706-719. ISSN 1948-7193

Nathaniel G.N. Milton (2011) Kissorphin Peptides used in the treatment of Alzheimer’s Disease, Creutzfeldt Jakob Disease or Diabetes Mellitus P. WO2011/144714 A1.

Nathaniel G.N. Milton (2011) Kissorphin Peptides used in the treatment of Alzheimer’s Disease, Creutzfeldt Jakob Disease or Diabetes Mellitus P. EP2388012A1.

Chilumuri, Amrutha and Ashioti, Maria and Nercessian, Amanda N. and Milton, Nathaniel G.N. (2013) Immunolocalization of kisspeptin associated with amyloid-β deposits in the pons of an Alzheimer’s disease patient. Journal of Neurodegenerative Diseases, 2013 . Article ID 879710. ISSN 2090-858X